Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University, Meizhou, China.
Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou Hospital Affiliated to Sun Yat-sen University, Meizhou, China.
J Clin Lab Anal. 2020 Apr;34(4):e23140. doi: 10.1002/jcla.23140. Epub 2019 Dec 3.
The aim of the study was to explore genotype distribution thalassemia and G6PD deficiency in Meizhou city, China.
A total of 16 158 individuals were involved in thalassemia genetic testing. A total of 605 subjects were screened for common Chinese G6PD mutations by gene chip analysis. Genotypes and allele frequencies were analyzed.
A total of 5463 cases carried thalassemia mutations were identified, including 3585 cases, 1701 cases, and 177 cases with α-, β-, and α + β-thalassemia mutations, respectively. -- (65.12%), -α (19.05%), and -α (8.05%) deletion were the main mutations of α-thalassemia, while IVS-II-654(C → T) (40.39%), CD41-42(-TCTT) (32.72%), -28(A → G) (10.11%), and CD17(A → T) (9.32%) mutations were the principal mutations of β-thalassemia in Meizhou. There were significant differences in allele frequencies in some counties. Genetic testing for G6PD deficiency, six mutation sites, and one polymorphism were detected in our study. A total of 198 alleles with the mutation were detected among 805 alleles (24.6%). G6PD Canton (c.1376 G → T) (45.96%), G6PD Kaiping (c.1388 G → A) (39.39%), and G6PD Gaohe (c.95 A → G) (9.09%) account for 94.44% mutations, followed by G6PD Chinese-5 (c.1024 C → T) (4.04%), G6PD Viangchan (c.871G → A) (1.01%), and G6PD Maewo (c.1360 C → T) (0.51%). There were some differences of the distribution of G6PD mutations among eight counties in Meizhou.
The -- , -α , and -α deletion were the main mutations of α-thalassemia, while IVS-II-654(C → T), CD41-42(-TCTT), -28(A → G), and CD17(A → T) mutations were the principal mutations of β-thalassemia in Meizhou. G6PD c.1376 G → T, c.1388 G → A, and c.95 A → G were the main mutations of G6PD deficiency. There were some differences of the distribution of thalassemia and G6PD mutations among eight counties in Meizhou.
研究目的是探讨中国梅州市人群地中海贫血和 G6PD 缺乏症的基因型分布。
对 16158 名个体进行地中海贫血基因检测。采用基因芯片分析对 605 例常见中国 G6PD 突变进行筛选。分析基因型和等位基因频率。
共发现 5463 例携带地中海贫血突变,其中α-、β-和α+β-地中海贫血突变分别为 3585、1701 和 177 例(占 65.12%)、-α(19.05%)和-α(8.05%)缺失是α-地中海贫血的主要突变,而 IVS-II-654(C→T)(40.39%)、CD41-42(-TCTT)(32.72%)、-28(A→G)(10.11%)和 CD17(A→T)(9.32%)突变是β-地中海贫血的主要突变。在一些县,等位基因频率存在显著差异。本研究检测了 G6PD 缺乏症的基因检测、6 个突变位点和 1 个多态性。在 805 个等位基因中检测到 198 个突变等位基因(占 24.6%)。G6PD Canton(c.1376 G→T)(45.96%)、G6PD Kaiping(c.1388 G→A)(39.39%)和 G6PD Gaohe(c.95 A→G)(9.09%)占突变的 94.44%,其次是 G6PD Chinese-5(c.1024 C→T)(4.04%)、G6PD Viangchan(c.871G→A)(1.01%)和 G6PD Maewo(c.1360 C→T)(0.51%)。梅州市 8 个县的 G6PD 突变分布存在差异。
--、-α和-α缺失是α-地中海贫血的主要突变,而 IVS-II-654(C→T)、CD41-42(-TCTT)、-28(A→G)和 CD17(A→T)突变是β-地中海贫血的主要突变。G6PD c.1376 G→T、c.1388 G→A 和 c.95 A→G 是 G6PD 缺乏症的主要突变。梅州市 8 个县的地中海贫血和 G6PD 突变分布存在差异。